teaser image
Recently, The Wellness Company announced a first of its kind human observational study of the off-label use of Ivermectin and Mebendazole in the treatment of cancer was published by the Anticancer Research Journal.

Sponsored Content By The Wellness Company


Monetary Metals Promo 1

AVGO results weigh on Tech as US payrolls report awaits - Newsquawk US Market Wrap

REAR VIEW: AVGO rev. misses as does next quarter semiconductor rev. from AI; Trump said US is "in the middle of my final negotiations to end the War"; Initial jobless claims jumps above top end of forecast range; US Challenger job cuts rise; BoJ reportedly mulling June hike, with another by year-end; Hot Swedish inflation; Cooler-than-expected Swiss inflation; Daly reiterates policy in good place; Schmid strikes hawkish tone; CRWD guidance underwhelms.

The Bond Market Holds The Key

History suggests the valuation headwind becomes much stronger once the 10-year moves meaningfully above 4.5%.
Zerohedge store image